Previous Article | Next Article 
Applied and Environmental Microbiology, September 2000, p. 4045-4049, Vol. 66, No. 9
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Growth and Acid Formation in
a Bacillus subtilis Pyruvate Kinase Mutant
B.
Fry,1
T.
Zhu,1
M. M.
Domach,2
R. R.
Koepsel,1
C.
Phalakornkule,2 and
M. M.
Ataai1,*
Department of Chemical Engineering,
University of Pittsburgh, Pittsburgh, Pennsylvania
152191 and Department of Chemical
Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania
152132
Received 18 January 2000/Accepted 5 July 2000
 |
ABSTRACT |
Based on measurements and theoretical analyses, we identified
deletion of pyruvate kinase (PYK) activity as a possible route for
elimination of acid formation in Bacillus subtilis cultures grown on glucose minimal media. Evidence consistent with the
attenuation of PYK flux has come from metabolic flux calculations,
metabolic pool and enzymatic activity measurements, and a series of
nuclear magnetic resonance experiments, all suggesting a nearly
complete inhibition of PYK activity for glucose-citrate fed cultures in which the amount of acid formation was nearly zero. In this paper, we
report the construction and characterization of a pyk
mutant of B. subtilis. Our results demonstrate an almost
complete elimination of acid production in cultures of the
pyk mutant in glucose minimal medium. The substantial
reduction in acid production is accompanied by increased
CO2 production and a reduced rate of growth. Metabolic analysis indicated a dramatic increase in intracellular pools of
phosphoenolpyruvate (PEP) and glucose-6-P in the pyk
mutant. The high concentrations of PEP and glucose-6-P could explain
the decreased growth rate of the mutant. The substantial accumulation of PEP does not occur in Escherichia coli pyk mutants. The
very high concentration of PEP which accumulates in the B. subtilis pyk mutant could be exploited for production of various aromatics.
 |
INTRODUCTION |
Acid production is among the
important factors that limit process stability and cell concentration
and thus cell-based biotechnological processes (e.g., see references
14, 23, and 25). Numerous approaches have been used in an attempt to reduce acid formation. One
mechanism involves maintaining low levels of glucose in fed batch
reactors (24, 27). While this can lead to increased cell
mass and product formation, it is a capital-intensive method. Manipulation of the growth media might also be used to reduce acid
formation relative to the amount of glucose consumed (13, 24).
Majewski and Domach (17) used a constrained network analysis
of the main metabolic pathways in conjunction with reported measurements of enzymatic activity levels to explain acid production by
bacterial cells. This analysis suggested that Escherichia
coli and Bacillus subtilis have excess glycolytic
capacity relative to the Krebs cycle. This idea is consistent with the
notion that given all the anabolic and catabolic tasks that metabolic
networks must perform, stoichiometric conflicts and other conflicts
arise, leading to imperfect coordination of all tasks. It is thus an overflow or "spilling" of excess carbon that leads to acid production.
In experiments using B. subtilis to test the overflow
hypothesis, it was found that a small amount of citrate added to
glucose minimal medium (0.1 mol of citrate/1 mol of glucose) caused the rate of glucose (or total carbon) use per cell to decline several-fold, while the maximal growth rate was not diminished (12).
Further, acid production was undetectable in the glucose-citrate
cultures. Subsequent work showed that productivity of recombinant
protein (units of protein/vol of culture-time) in glucose-citrate
medium was 5- to 10-fold higher (26), further
emphasizing the utility of reducing acid production.
Although there have been several efforts to reduce acid formation in
E. coli by metabolic engineering (6, 8), there has been no report on metabolic engineering of B. subtilis.
Based on measurements and theoretical analyses, we identified pyruvate kinase (PYK) as the activity most likely affected by growth in glucose-citrate medium (12, 15). At the pH of the medium, citrate is transported by a symport with divalent metal ions
(especially Ca2+) to maintain electroneutrality.
Ca2+ is known to be a strong inhibitor of the enzyme PYK in
procaryotes (3). Intracellular concentrations of
Ca2+ are increased by cotransport with citrate to a level
where PYK inhibition occurs. PYK inhibition would consequently elevate
the phosphoenolpyruvate (PEP) concentration, which is known to inhibit the enzyme phosphofructokinase (PFK). The glucose flux through the
terminal reactions of glycolysis is reduced, thus eliminating acid
overflow. Measurements of intracellular metabolites were consistent
with significant attenuation of PYK flux (13). Pyruvate levels were significantly decreased, and PEP and glucose-6-phosphate levels were elevated, for cells grown in glucose and citrate, compared
to results for those grown with glucose alone (13). Thus
there is biochemical evidence that is consistent with the inhibition of
PYK suggested by the flux balances (12) and linear programming-generated flux scenarios (15).
Further evidence consistent with the attenuation of PYK flux has come
from a series of nuclear magnetic resonance experiments measuring the
13C enrichment at specific carbons of glutamate when
[1-13C]glucose is used as a substrate (21).
The relative enrichment at each carbon in glutamate can be used to
predict the dominant metabolic route operating in the cell. Nuclear
magnetic resonance analysis of extracts of B. subtilis cells
growing in glucose-citrate media indicates a nearly complete inhibition
of PYK activity.
Taken together, the data presented above suggest that mutation of the
pyk gene would lead to a strain that would show reduced acid
production when grown in glucose minimal media. Indeed, it is possible
that reducing the PYK flux could be a generic strategy for eliminating
acid production.
In this paper, we report the construction and characterization of a
pyk mutant of B. subtilis. Our results
demonstrate an almost complete elimination of acid production in
cultures of the pyk mutant in glucose minimal medium. The
substantial reduction in acid production is accompanied by increased
CO2 production and a somewhat reduced growth rate.
Metabolic analysis indicated a dramatic increase in intracellular pools
of PEP and glucose-6-P in the pyk mutant. The high
concentrations of PEP and glucose-6-P could explain the decreased
growth rate of the mutant.
 |
MATERIALS AND METHODS |
Construction of a B. subtilis mutant.
The
primers BspykF (5' GGCAAGAACGTTGGAATTC 3') and BspykR
(5' CGAGGGCAAGCTTTCTGG 3') were designed using the sequence
of the B. subtilis pyk gene obtained from GenBank and used
to amplify a 1,050-bp fragment from B. subtilis genomic DNA.
The fragment contained EcoRI and HindIII
sites at the 5' and 3' ends, respectively. The fragment was digested
with EcoRI and HindIII and cloned into the
E. coli plasmid pUC19. Following isolation and
characterization of the pUC/pyk plasmid, a chloramphenicol resistance
gene (Cmr) was inserted in the middle of the cloned
pyk DNA. The Cmr gene was obtained as a
MspI-TaqI fragment from plasmid pUB110, and that
fragment was cloned into a ClaI site in the middle of the
cloned B. subtilis pyk DNA. This plasmid,
pUC/BSPYK::CAM, was grown in E. coli, purified,
linearized at the EcoRI site, and used to transform
competent wild-type B. subtilis (ATCC 6051) as described
previously (4). Transformants were selected on plates
containing 3 µg of chloramphenicol/ml and then checked for the
presence of plasmid DNA by agarose gel electrophoresis. Twelve
candidate clones were identified and further characterized by PCR.
Chromosomal DNA from the candidate colonies was isolated and subjected
to PCR using the primers originally used to isolate the pyk
fragment. Six of the colonies displayed an amplified band of about 2.7 kb (1 kb of pyk DNA and 1.7 kb for the Cmr
gene), and wild-type B. subtilis DNA showed an approximately 1-kb band.
Growth medium.
One liter of media contained the following:
1 g of NH4Cl, 0.04 g of tryptophan, 1.0 g of
KH2PO4, 2.72 g of
K2HPO4, 0.284 g of
Na2SO4, 0.17 g of NaNO3,
0.15 g of KCl, 25 mg of MgCl2 · 6H2O, 2.16 mg of FeCl3 · 6H2O, 15 mg of MnCl2 · 4H2O,
22 mg of CaCl2 · 6H2O, and 2.5 ml of
10% antifoam B. The concentrations of glucose and other carbon sources
used in each experiment are noted in the text.
Cultivation and measurement of glucose and acids.
Fermentation vessels with a 2-liter capacity (Applikon, Austin, Tex.)
were used. An online data acquisition system (1) collected
data for the CO2 evolution rate from a Dycor mass
spectrometer (Ametek, Pittsburgh, Pa.) using a standard gas mixture for
calibration. The air flow rate was set at 2 liters/min, and the pH was
constrained between 6.7 and 6.9. Optical density was measured offline
using a Lambda 6 spectrophotometer (Perkin-Elmer, Norwalk, Conn.) from our calibrations (1 optical density at 660 nm [OD660] = 0.35 g of cell dry weight/liter). The glucose concentration was
measured enzymatically (Sigma kit 16-UV; Sigma Chemicals, St. Louis,
Mo.). To measure the concentrations of organic acids (lactate, acetate, acetoin, formate, fumarate, malate, pyruvate, succinate, and citrate), a high-pressure liquid chromatography gradient module (Bio-Rad, Richmond, Calif.) equipped with a UV-visible light monitor was employed
(13).
Measurements of intracellular glucose-6-phosphate, PEP, and
pyruvate.
For metabolite assays, cell extracts were prepared using
the formic acid extraction method (9). Flasks were immersed
in liquid nitrogen and chilled to 4°C. A sorval Superspeed RC2-B Automatic refrigerated centrifuge was used for harvesting the cells.
The cell pellet was resuspended in 1 N formic acid at 4°C and
incubated at 4°C for 1 h. Cell debris was then removed by centrifugation. The supernatant was then lyophilized and resuspended in
0.2% of the original culture volume. A Perkin-Elmer fluorospectrometer was used for the assays in which NADPH or NADH served as the indicator, with the absorption set at 340 nm and emission measured at 460 nm.
Glucose-6-phosphate, PEP, pyruvate, and citrate were measured according
to the method of Lowry and Passonneau (16).
Assay of pyruvate kinase.
Pyruvate kinase assays were
performed for both the wild-type and the pyk mutant as
previously reported (18).
 |
RESULTS |
Pyruvate kinase activities.
The specific PYK activity
(measured in units/milligram of protein) in the extracts of the mutant
cells was 0.02 ± 0.002, significantly lower than the wild type
level (0.09 ± 0.007). The low base level of activity for the
mutant may reflect the contribution from other reactions in the cell
extract. To the best of our knowledge, there is no second
pyk gene in B. subtilis. This experiment has been repeated at least five times, and we always see the low level of
activity. Moreover, while the specific PYK activity in the wild-type
cell extract varies with changes in the PEP concentration (e.g., 0.036 with 2.5 mM PEP and 0.09 with 5 mM PEP), as expected (18),
the specific activity for the mutant was at about 0.02 independent
of the PEP concentration. The specific activity of 0.02 was also
present when there was no PEP in the assay mixture. Thus, we are
confident that this low level of activity represents the background
reading of the cell extract mixture. Indeed, in our experiment with the
E. coli pyk mutant, in which both PYK I and PYK II are
inactivated, this low level is also observed.
Growth on glucose minimal media.
The results of growth in
batch cultures with 8 g of glucose/liter are shown in Fig.
1. The mutant exhibited a considerably longer lag time and a lower growth rate than did the wild type (Fig.
1A). Although visually, on a linear scale, it appears that the growth
rate of the mutant was not dramatically lower than that of the
wild-type, displaying the data on a log scale will reveal that indeed
the maximum growth rate of the mutant was only about 30% of that of
the wild type. The longer lag phase and lower growth rate have also
been observed consistently in our shake-flask experiments, which were
repeated many times (data not shown). The final cell concentration was
slightly lower than that for the wild type (Fig. 1A), but a significant
portion of glucose remained unutilized (Fig. 1B). Thus, the cell yield
on glucose was higher for the mutant. The same experiment was also
repeated in the reactor experiment with 4.4 g of glucose/liter in
medium (data not shown). The results displayed the same pattern of a significantly longer lag time and a slower maximum growth rate. Despite
the longer lag period and slower growth rate in the glucose (4.4 g/liter) culture, the mutant reached a slightly higher cell mass.
Further, all of the glucose was consumed in both the wild-type and the
mutant cultures. While there were some differences in growth
characteristics between the mutant and the wild type, the major
differences were in the production of acids and intracellular metabolite pools.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Changes in the OD660 (A) and glucose and
CO2 levels (B) in the batch cultures of the wild type (WT)
and the pyk mutant (MT) of B. subtilis with an
initial glucose concentration of about 8 g/liter.
CO2/N2 is the molar ratio of CO2 to
N2 in the effluent gas stream. Since the amount of
N2 does not change, the variation in the
CO2/N2 ratio represents the changes in the
CO2 concentration.
|
|
Acid production by wild-type and pyk mutant
strains.
The concentrations of acidic metabolic by-products found
in the culture and the carbon balances are given in Table
1. The data in Table 1 correspond to the
end of exponential phase of growth. The data show a somewhat higher
output of carbon than the carbon input as glucose. This difference
might be attributed, at least partly, to an overestimation of the
amount of CO2. The percentage of carbon in biomass was
calculated based on the formula of 1 OD660 = 0.35 g of cell dry weight/liter and a cell's carbon content of 45%. These
values are fairly conservative estimates, and thus the cell's carbon
content should not be overestimated. Moreover, the assay kit used for
measuring the glucose concentration is reliable and has an error margin
of less than 5%.
The data reveal that in contrast to results for the wild-type cultures,
there was no acid formed by the mutant, but the amount
of
CO
2 formation was substantially higher in the mutant
cultures.
The mutant also converted a higher percentage of glucose
carbon
to cell mass. The low amount of acid formation in the
pyk mutant
is consistent with our hypothesis that levels of
acid formation
will be low in the mutant. Since there was very little
or no acid
formed in the mutant cultures, the lower growth rate of the
mutant
cannot be attributed to the inhibitory role of acidic
by-products,
such as
acetate.
Intracellular metabolite pools.
We speculated that high levels
of PEP might be accumulating in the pyk mutant of B. subtilis. High levels of PEP could potentially be responsible for
the lower growth rate of the mutant. High PEP levels would inhibit
phosphofructokinase (2, 13) and lead to accumulation of
glucose 6-P. High glucose 6-P levels in turn would lead to a lower rate
of glucose consumption. For the mutant, the concentration of PEP is
very low and often undetectable in bacteria. Experiments were conducted
to measure the PEP and glucose-6-P levels for the wild type and the
mutant. We found a dramatic increase in PEP and glucose 6-P
concentrations in the pyk mutant of B. subtilis.
The PEP concentration for the wild type was undetectable (below 0.02 mM), and the concentration for the mutant was 1.30 mM (with a standard
deviation of ±0.05 in two independent experiments). Furthermore, the
concentration of glucose-6-P was about 1.36 mM (standard deviation,
±0.12 in two independent experiments) for the mutant but below 0.10 mM
for the wild type. The high PEP levels in the mutant open the
possibility of using this strain as a starting point in the
construction of strains with the capacity to produce products that use
PEP as a primary substrate (e.g., phenylalanine).
Growth in glucose-pyruvate medium.
The hypothesis that PEP
accumulation and the resultant pyruvate deficit were responsible for
the lower growth rate of the mutant was further confirmed by performing
an experiment in which a small amount of pyruvate (0.2 mol of
pyruvate/mol of glucose) was included in the growth medium. The
pyruvate addition restored the growth rate of the mutant to the
wild-type level and resulted in about a 15% higher final cell density
than that for the wild-type cultures. The addition of pyruvate (0.2 mol
of pyruvate/mol of glucose) had very little effect on either the growth
rate or the final cell density for the wild-type culture.
 |
DISCUSSION |
The lower acetic acid production for the pyk mutant of
B. subtilis is encouraging. However, as indicated by the
pyruvate addition experiment, the B. subtilis mutant may be
experiencing a pyruvate limitation when PYK activity is completely
eliminated. This limitation could potentially be alleviated by
controlling the expression of the pyk gene at a low but
finite level, thereby reducing the high intracellular concentration of PEP.
The high intracellular concentration of PEP found in the pyk
mutant of B. subtilis may be exploited for the production of various aromatic compounds. Successful commercial production of aromatic compounds in bacteria requires high-yield conversion of
glucose to such products. Some of the commercially important aromatic
products are tryptophan, tyrosine, phenylalanine, quinic acid,
catechol, and adipic acids. The first dedicated step of the pathways
leading to formation of various aromatics is the condensation of E4P
and PEP catalyzed by DAHP synthase. Several attempts have been made to
increase the in vivo pools of PEP in E. coli. They include
the deletion of the PEP-consuming reaction PEP carboxylase
(19) or pyruvate kinase (22) and use of either an
alternative transport system utilizing ATP as the phosphate donor
rather than PEP for the phosphotransferase (PTS) system (10)
or an alternative carbon source, such as xylose, which does not rely on
the PTS system (20). Although these strategies appeared to
increase the level of PEP, the increase was not substantial (still
remaining below the detection limit) or was not measured (10). Recently, Chen et al. (5) evaluated
pts mutations for effects on production of phenylalanine
from E. coli. This strategy did not increase the PEP pool or
the production of the phenylalanine.
Our recent work with an E. coli pyk mutant (strain PB25
[22]) lacking both PYK I and PYK II activities indicated that the PEP
pool in the E. coli pyk mutant was not substantially greater than in the wild type (T. Zhu et al., unpublished data). Unlike the
B. subtilis pyk mutant, the E. coli pyk mutant
had a growth rate similar to that of the wild type. The difference
between the B. subtilis and E. coli networks is
primarily at the level of oxaloacetate formation (see Fig.
2 for a schematic). In B. subtilis, oxaloacetate is formed from pyruvate, but in E. coli, PEP is the precursor. Thus, while the E. coli pyk
mutant cannot convert PEP to pyruvate via PYK activity, PEP can enter
the trichloroacetic acid cycle via PEP carboxylase activity (PEP to
oxaloacetate). PEP may even be converted to pyruvate via the
combination of PEP carboxylase and malic enzyme activities. In
contrast, in the B. subtilis mutant PEP can only be
converted to pyruvate via the PTS system; there are no other reactions
that can convert PEP to trichloroacetic acid cycle metabolites for
further processing. Consequently, substantial accumulation of PEP and
reduction of glucose uptake are likely.
In summary, we have constructed a B. subtilis pyk mutant and
quantified its growth characteristics. There was very little or no acid
formed in the mutant when it was grown on up to 8 g of
glucose/liter, a condition under which the wild type produces as much
as 2.75 g of acid by-products/liter (see Table 1). Furthermore, we
have shown that in contrast to results for an E. coli pyk
mutant, substantial accumulation of PEP occurs in our B. subtilis
pyk mutant. This high accumulation of PEP should be further
explored for production of various aromatics in B. subtilis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Chemical Engineering, University of Pittsburgh, 1249 Benedum Hall,
Pittsburgh, PA 15219. Phone: (412) 624-9630. Fax: (412) 624-9639. E-mail: ataai{at}engrng.pitt.edu.
 |
REFERENCES |
| 1.
|
Beitle, R. R., and M. M. Ataai.
1991.
A unique cultivation monitoring and control system.
Biotechnol. Tech.
5:77-82.
|
| 2.
|
Blangy, D.,
H. Buc, and J. Monod.
1968.
Kinetics of the allosteric interactions of phosphofructokinase from Escherichia coli.
J. Mol. Biol.
31:13-35[CrossRef][Medline].
|
| 3.
|
Boiteux, A.,
M. Markus,
T. Plesser,
B. Hess, and M. Malcovati.
1983.
Interaction of pyruvate kinase from Escherichia coli with fructose 1,6-biphosphate and calcium ions.
Biochem. J.
211:631-640[Medline].
|
| 4.
|
Bron, S.
1990.
Plasmids, p. 75-174.
In
C. R. Harwood, and S. M. Cutting (ed.), Molecular biological methods for bacillus. John Wiley & Sons, Inc., New York, N.Y.
|
| 5.
|
Chen, R. Z.,
V. Hatzimanikatis,
W. M. G. J. Yap,
P. W. Postma, and J. E. Bailey.
1997.
Metabolic consequences of phosphotransferase (PTS) mutation in a phenylalanine-producing recombinant Escherichia coli.
Biotechnol. Prog.
13:768-775[CrossRef][Medline].
|
| 6.
|
Chou, C. H.,
G. N. Bennett, and K. Y. San.
1994.
Effect of modifying glucose uptake using genetic engineering techniques on high level recombinant protein production in Escherichia coli dense culture.
Biotechnol. Bioeng.
44:952-969[CrossRef].
|
| 7.
|
Evans, P. R., and P. J. Hudson.
1979.
Structure and control of phosphofructokinase from Bacillus stearothemophilus.
Nature
279:500-504[CrossRef][Medline].
|
| 8.
|
Farmer, W. R., and J. C. Liao.
1997.
Reduction of aerobic acetate production by Escherichia coli.
Appl. Environ. Microbiol.
63:3205-3210[Abstract].
|
| 9.
|
Fisher, S. H., and B. Magasanik.
1984.
Synthesis of oxaloacetate in Bacillus subtilis mutants lacking the a-ketoglutarate dehydrogenase enzyme complex.
J. Bacteriol.
158:55-62[Abstract/Free Full Text].
|
| 10.
|
Flores, N.,
J. Xiao,
A. Berry,
F. Boliver, and F. Valle.
1995.
Pathway engineering for the production of aromatic compounds in Escherichia coli.
Nat. Biotechnol.
14:620-623.
|
| 11.
|
Goel, A.,
J. Ferrance, and M. M. Ataai.
1993.
Analysis of metabolic fluxes in batch and continuous cultures of Bacillus subtilis.
Biotechnol. Bioeng.
42:686-696[CrossRef].
|
| 12.
|
Goel, A.,
J.-W. Lee,
M. M. Domach, and M. M. Ataai.
1995.
Suppressed acid formation by cofeeding glucose and citrate in Bacillus cultures: emergence of pyruvate kinase as a potential metabolic engineering site.
Biotechnol. Prog.
11:380-386[CrossRef][Medline].
|
| 13.
|
Goel, A.,
M. M. Domach, and M. M. Ataai.
1999.
Metabolite fluxes, pools and enzyme measurements suggest a tighter coupling of the energetic and biosynthetic reactions requires reduction in pyruvate kinase flux.
Biotechnol. Bioeng.
64:129-134[CrossRef][Medline].
|
| 14.
|
Ko, Y.-F.,
W. E. Bentley, and W. A. Weigand.
1993.
An integrated modeling approach to describe the energy efficiency of E. coli fermentation under oxygen-limited conditions; cellular energetics, carbon flux, and acetate production.
Biotechnol. Bioeng.
42:843-853[CrossRef].
|
| 15.
|
Lee, J.,
A. Goel,
M. M. Ataai, and M. M. Domach.
1997.
Supply-side analysis of growth of Bacillus subtilis on glucose-citrate medium: feasible network alternatives and yield optimality.
Appl. Environ. Microbiol.
63:710-718[Abstract].
|
| 16.
|
Lowry, O. H., and O. V. Passonneau.
1973.
A flexible system of enzymatic analysis.
Academic Press, Inc., New York, N.Y.
|
| 17.
|
Majewski, R. A., and M. M. Domach.
1990.
Simple constrained-optimization view of acetate overflow in E. coli.
Biotechnol. Bioeng.
35:732-738[CrossRef].
|
| 18.
|
Malcovati, M., and G. Valentini.
1982.
AMP and fructose 6-phosphate activated pyruvate kinase from E. coli.
Methods Enzymol.
90:170-179.
|
| 19.
|
Miller, J. E.,
K. C. Beckman,
M. J. O'Connor, and R. T. Hatch.
1987.
Production of phenylalanine and organic acids by PEP carboxylase deficient mutants of Escherichia coli.
J. Ind. Microbiol.
2:143-149.
|
| 20.
|
Patnaik, R.,
R. G. Spitzer, and J. C. Liao.
1994.
Pathway engineering for production of aromatics in Escherichia coli: confirmation of stoichiometric analysis of independent modulation of AroG, TktA, and Pps activities.
Biotechnol. Bioeng.
46:361-370.
|
| 21.
|
Phalakornkule, C.,
B. Fry,
T. Zhu,
R. Koepsel,
M. M. Ataai, and M. M. Domach.
2000.
13C NMR evidence for pyruvate kinase flux attenuation underlying suppressed acid formation in Bacillus subtilis.
Biotechnol. Prog.
16:169-175[CrossRef][Medline].
|
| 22.
|
Ponce, E.,
N. Flores,
A. Martinez,
F. Bolivar, and F. Valle.
1998.
Simulation of glucose catabolism through the pentose pathway by the absence of the two pyruvate kinase isoenzymes in Escherichia coli.
Biotechnol. Bioeng.
58:292-295[CrossRef][Medline].
|
| 23.
|
Shiloach, J.,
J. Kaufman,
A. S. Guillard, and R. Fass.
1996.
Effect of glucose supply strategy on acetate accumulation, growth, and recombinant protein production by Escherichia coli BL21 (lambda DE3) and Escherichia coli JM109.
Biotechnol. Bioeng.
49:421-428[CrossRef].
|
| 24.
|
Snay, J.,
J. Jeong, and M. M. Ataai.
1989.
Effect of growth conditions on carbon utilization and organic by-product formation.
Biotechnol. Prog.
5:63-69.
|
| 25.
|
Van de Walle, M., and J. Shiloach.
1998.
Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation.
Biotechnol. Bioeng.
57:71-78[CrossRef][Medline].
|
| 26.
|
Vierheller, C.,
A. Goel,
M. M. Domach, and M. M. Ataai.
1995.
Sustained and constitutive high levels of protein production in continuous cultures of B. subtilis.
Biotechnol. Bioeng.
47:520-525[CrossRef].
|
| 27.
|
Zabriskie, D. W., and E. J. Arcuri.
1986.
Factors influencing productivity of fermentations employing recombinant microorganisms.
Enzyme Microb. Technol.
16:933-941[CrossRef].
|
Applied and Environmental Microbiology, September 2000, p. 4045-4049, Vol. 66, No. 9
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cunningham, D. S., Liu, Z., Domagalski, N., Koepsel, R. R., Ataai, M. M., Domach, M. M.
(2009). Pyruvate Kinase-Deficient Escherichia coli Exhibits Increased Plasmid Copy Number and Cyclic AMP Levels. J. Bacteriol.
191: 3041-3049
[Abstract]
[Full Text]
-
Zhu, T., Pan, Z., Domagalski, N., Koepsel, R., Ataai, M. M., Domach, M. M.
(2005). Engineering of Bacillus subtilis for Enhanced Total Synthesis of Folic Acid. Appl. Environ. Microbiol.
71: 7122-7129
[Abstract]
[Full Text]